Testing a new drug for high blood pressure
Part of Heart & circulation, Hormones & metabolism clinical trials.
This trial tests a new medicine called SPC1001 Low to see if it can safely lower blood pressure in people with essential hypertension (high blood pressure with no known cause). If you are between 19 and 75 years old and have mild to moderate high blood pressure, this study might be an option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 19 and 75 years old.
- You have been diagnosed with essential hypertension (high blood pressure with no clear cause).
- Your blood pressure is not extremely high (systolic under 180 mmHg and diastolic under 110 mmHg).
- You are able to attend screening and follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing an experimental drug, QLS1410, to see if it can lower blood pressure in people whose blood pressure is still high even after taking two or more medications.
This study looks at how well blood pressure is managed in people with hypertension. It may help find better ways to control blood pressure and reduce risks like heart attack or stroke.
This trial tests an oral medication called SPC1001 to see if it can safely lower blood pressure in people with essential hypertension (high blood pressure not caused by another condition). It may help if you have mild to moderate high blood pressure.
This study tests five new medicines to see if they can lower blood pressure in people with mild to moderate essential hypertension. It may help you if your blood pressure is not well controlled and you are willing to take the study medicine for a period of time.
This study tests a new blood pressure medication to see if it is safe and effective for people with high blood pressure. It may help lower your blood pressure and reduce health risks.
This study tests a new combination of three medications (THP-00101, THP-00102, and THP-00103) for people with type 2 diabetes and essential high blood pressure. It aims to see if this combination is safe and effective compared to standard treatments.
Hear when a new Hypertension (HTN) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.